moderna shares Archives

MRNA Stock Down 10%, Moderna Didn’t Produce Data Critical to Assessing COVID-19 Vaccine

As Stat News has reported, it is too early to assess the COVID-19 vaccine offered by Moderna. Most of what Moderna disclosed “were words, not data”, while the critical information has been withheld. MRNA stock is down.

MRNA Stock Up 10%, Moderna CEO Says Supply of Coronavirus Vaccine Will Be Limited

Business News, Market News, News, Stocks, Wall Street

By Teuta Franjkovic May 8, 2020

It has become known that the supply of Moderna’s coronavirus vaccine will be limited and the U.S. government will help to choose who will be the first to get it. Meanwhile, today Moderna (MRNA) stock is around 10% up.

Moderna (MRNA) Stock Rose 4.94% on Friday, Moderna CEO Stephane Bancel Becomes Billionaire

Business News, Market News, News, Stocks, Wall Street

By Steve Muchoki Apr 6, 2020

On Friday, Moderna (MRNA) stock rose by 4.94% breaking out the $32 resistance level. Clinching above $34 has helped Moderna CEO Stephane Bancel to join the list of billionaires.

Editor's Choice, Market News, Stocks

MRNA Stock 11.90% Up, Moderna Plans to Begin COVID-19 Vaccine Human Trials This Spring

By Darya Rudz Apr 3, 2020

According to Moderna Chairman Noubar Afeyan, the second phase of human trials of the COVID-19 vaccine might begin this spring. If the testing is successful, the 3rd phase will immediately begin. MRNA stock went up.

Business News, Market News, News, Stocks, Wall Street

Moderna (MRNA) Stock Rises 3.61% Today, Coronavirus Vaccine Results Are Still Months Away

By Christopher Hamman Mar 26, 2020

Moderna (MRNA) stock price has risen at the possibility of having a new coronavirus vaccine by the fall of this year. Trials are expected to have been completed in two months’ time.